The researchers recently published their findings in Nature Communications, detailing a wearable platform that enables precise drug dosing through continuous, real-time monitoring of disease and drug markers. Based on microneedles, the system continuously monitors—via the interstitial fluid in the skin—glucose levels and the level of metformin, a common diabetes medication. “This is a new chapter in dynamic, personalized, real-time disease management,” said Prof. Haick.

The interdisciplinary research was led by Prof. Haick of the Wolfson Faculty of Chemical Engineering at the Technion-Israel Institute of technology, Jian Yang, Xia Gong, and Ying Zheng, in collaboration with Prof. Changqing Yi and Prof. Lelun Jiang from Sun Yat-sen University in China.